BioCentury
ARTICLE | Clinical News

Mecasermin rinfabate: Phase II data

July 11, 2016 7:00 AM UTC

Top-line data from the double-blind, international Phase II ROPP-2008-01 trial in 121 premature infants born at a gestational age of 23 weeks-27 weeks and 6 days showed that once-daily 250 ug/kg IV SH...